Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer

Documenti analoghi

• Response to ‘Letters to the Editor’ comments on the paper ‘Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy’
  di: Joost van Drumpt, et al.
  Pubblicazione: (2026)
• Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat
  di: Annemieke M. Peters van Ton, et al.
  Pubblicazione: (2025)
• In depth: The drug interaction between trimethoprim‐sulfamethoxazole and folic acid/folinic acid
  di: Emmy Boerrigter, et al.
  Pubblicazione: (2024)
• Active surveillance in the elderly: Is it the right strategy to avoid overtreatment?
  di: Christophe K. Mannaerts, et al.
  Pubblicazione: (2026)
• Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer
  di: Michiel Vlaming, et al.
  Pubblicazione: (2025)